Jonas Kloepper
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 3
- HER2/EGFR in Cancer Research 1
- Cancer Immunotherapy and Biomarkers 1
-
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- Dai Fukumura (4 shared papers)Dan G. Duda (2 shared papers)Zohreh Amoozgar (2 shared papers)Gino B. Ferraro (3 shared papers)Vasileios Askoxylakis (2 shared papers)Miguel O. Bernabéu (1 shared paper)Meenal Datta (1 shared paper)Costas Arvanitis (1 shared paper)
- Journals
- Nature Reviews Clinical Oncology (1 paper)Cell Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Plastic Reconstructive & Aesthetic Surgery (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesGermanyHungary
In The Last Decade
Jonas Kloepper
6 papers receiving 1.8k citations
Jonas Kloepper's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 730
- Hepatology 154
- Immunology 390
- Cancer Research 209
- Pulmonary and Respiratory Medicine 329
Countries citing papers authored by Jonas Kloepper
This map shows the geographic impact of Jonas Kloepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Kloepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Kloepper more than expected).
Fields of papers citing papers by Jonas Kloepper
This network shows the impact of papers produced by Jonas Kloepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Kloepper. The network helps show where Jonas Kloepper may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonas Kloepper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges Hit paper breakdown → | 2018 | 1438 |
| 2 | 2018 | 183 | |
| 3 | 2017 | 82 | |
| 4 | 2008 | 57 | |
| 5 | 2015 | 57 | |
| 6 | 2022 | 3 |
About Jonas Kloepper
Jonas Kloepper is a scholar working on Oncology, Molecular Biology, Cellular and Molecular Neuroscience, Dermatology and Biomaterials, having authored 6 papers that have together received 1.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (1 paper), Facial Rejuvenation and Surgery Techniques (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Mathematical Biology Tumor Growth (1 paper), T-cell and B-cell Immunology (1 paper) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Oncology (730 citations), Hepatology (154 citations), Immunology (390 citations), Cancer Research (209 citations) and Pulmonary and Respiratory Medicine (329 citations). Jonas Kloepper has collaborated with scholars based in United States, Germany and Hungary. Frequent co-authors include Dai Fukumura, Dan G. Duda, Zohreh Amoozgar, Gino B. Ferraro, Vasileios Askoxylakis, Miguel O. Bernabéu, Meenal Datta, Costas Arvanitis, Yutong Guo and Nathan McDannold. Their work appears in journals such as Nature Reviews Clinical Oncology, Cell Research, Proceedings of the National Academy of Sciences, Journal of Plastic Reconstructive & Aesthetic Surgery and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.